ID: ALA4789939

Max Phase: Preclinical

Molecular Formula: C35H58N8O6S2

Molecular Weight: 751.03

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CNC(=O)COCC(=O)NCCCCNC(=O)COCC(=O)NC[C@H]1CC[C@H](/N=C(\NC2CCCCC2)SCC2=CSC3=NC(C)(C)CN23)CC1

Standard InChI:  InChI=1S/C35H58N8O6S2/c1-35(2)24-43-28(23-51-34(43)42-35)22-50-33(40-26-9-5-4-6-10-26)41-27-13-11-25(12-14-27)17-39-32(47)21-49-20-31(46)38-16-8-7-15-37-30(45)19-48-18-29(44)36-3/h23,25-27H,4-22,24H2,1-3H3,(H,36,44)(H,37,45)(H,38,46)(H,39,47)(H,40,41)/t25-,27-

Standard InChI Key:  CFYAXNRXEOCJSZ-DUYHBEBVSA-N

Associated Targets(Human)

CXCR4 Tclin C-X-C chemokine receptor type 4 (3338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GHOST CXCR4 (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 reverse transcriptase (18245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 751.03Molecular Weight (Monoisotopic): 750.3921AlogP: 2.50#Rotatable Bonds: 19
Polar Surface Area: 174.85Molecular Species: BASEHBA: 11HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.72CX LogP: 0.70CX LogD: -0.61
Aromatic Rings: 0Heavy Atoms: 51QED Weighted: 0.08Np Likeness Score: -0.71

References

1. Ma H,Wang H,Li M,Barreto-de-Souza V,Reinecke BA,Gunta R,Zheng Y,Kang G,Nassehi N,Zhang H,An J,Selley DE,Hauser KF,Zhang Y.  (2020)  Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry.,  11  (11): [PMID:33214847] [10.1021/acsmedchemlett.0c00444]

Source